Pediatric studies and hematological malignancies

C McKinnon1

  • 1Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1P 6LB, UK. colinm@cursci.co.uk

Idrugs : the Investigational Drugs Journal
|August 30, 2005
PubMed

Insights

This summary highlights key findings from the American Society of Clinical Oncology meeting poster sessions. It covers innovative cancer research and clinical trial advancements presented by experts.

Area of Science:

  • Oncology
  • Clinical Research
  • Cancer Therapeutics

Background:

  • The American Society of Clinical Oncology (ASCO) meeting is a premier event for presenting cutting-edge cancer research.
  • Poster sessions offer a platform for detailed discussion of novel studies and preliminary findings.

Purpose of the Study:

  • To curate and present a selection of noteworthy studies from the ASCO poster sessions.
  • To provide a concise overview of significant advancements in clinical oncology.

Main Methods:

  • Review of abstracts and presentations from ASCO poster sessions.
  • Selection of studies based on novelty, potential impact, and clinical relevance.

Main Results:

  • Identification of promising research across various cancer types and treatment modalities.
  • Highlighting of emerging trends in cancer care and patient management.

Conclusions:

  • The ASCO poster sessions showcased a wealth of innovative research.
  • These selected studies represent important developments in the field of clinical oncology.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...